BDRX
Biodexa Pharmaceuticals
BDRX
BDRX
4 hedge funds and large institutions have $17K invested in Biodexa Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
4
Holders Change
-1
Holders Change %
-20%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
GI
GAMMA Investing
Foster City,
California
|
+$9.09K |
| 2 |
SS
SBI Securities
Tokyo,
Japan
|
+$4.9K |
Top Sellers
| 1 |
UBS Group
Zurich,
Switzerland
|
-$14.6K |
| 2 |
Morgan Stanley
New York
|
-$924 |
| 3 |
RhumbLine Advisers
Boston,
Massachusetts
|
-$211 |
| 4 |
CIM
Contravisory Investment Management
Norwell,
Massachusetts
|
-$53 |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
GI
1
GAMMA Investing
Foster City,
California
| $10.3K | +$9.09K | +1,051 | +735% |
|
|
SS
2
SBI Securities
Tokyo,
Japan
| $4.9K | +$4.9K | +567 | New |
|
|
3
UBS Group
Zurich,
Switzerland
| $1.72K | -$14.6K | -1,684 | -89% |
|
|
4
RhumbLine Advisers
Boston,
Massachusetts
| $59 | -$211 | -25 | -78% |
|
|
5
Morgan Stanley
New York
| – | -$924 | -70 | Closed |
|
|
CIM
6
Contravisory Investment Management
Norwell,
Massachusetts
| – | -$53 | -4 | Closed |
|